DK59691A - Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring - Google Patents

Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring Download PDF

Info

Publication number
DK59691A
DK59691A DK059691A DK59691A DK59691A DK 59691 A DK59691 A DK 59691A DK 059691 A DK059691 A DK 059691A DK 59691 A DK59691 A DK 59691A DK 59691 A DK59691 A DK 59691A
Authority
DK
Denmark
Prior art keywords
procedure
improved stability
stability under
under drying
preparing liposomes
Prior art date
Application number
DK059691A
Other languages
Danish (da)
English (en)
Other versions
DK59691D0 (da
Inventor
Paul Gardner Schmidt
Gary Fujii
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of DK59691D0 publication Critical patent/DK59691D0/da
Publication of DK59691A publication Critical patent/DK59691A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Cosmetics (AREA)
DK059691A 1988-10-05 1991-04-04 Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring DK59691A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25368088A 1988-10-05 1988-10-05
PCT/US1989/004222 WO1990003795A1 (fr) 1988-10-05 1989-10-03 Procede de fabrication de liposomes a stabilite amelioree pendant le sechage

Publications (2)

Publication Number Publication Date
DK59691D0 DK59691D0 (da) 1991-04-04
DK59691A true DK59691A (da) 1991-04-04

Family

ID=22961272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK059691A DK59691A (da) 1988-10-05 1991-04-04 Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring

Country Status (13)

Country Link
US (1) US5817334A (fr)
EP (1) EP0437479B1 (fr)
JP (1) JP2792702B2 (fr)
AT (1) ATE107502T1 (fr)
AU (1) AU612285B2 (fr)
CA (1) CA2000219A1 (fr)
DE (1) DE68916439T2 (fr)
DK (1) DK59691A (fr)
FI (1) FI902249A7 (fr)
IE (1) IE64559B1 (fr)
IL (1) IL91901A (fr)
NO (1) NO180363C (fr)
WO (1) WO1990003795A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
WO1993004672A1 (fr) * 1991-09-11 1993-03-18 Pitman-Moore, Inc. Procede de renforcement du systeme immunitaire d'un hote a l'aide de polypeptides encapsules dans des liposomes
JP3329554B2 (ja) * 1993-03-10 2002-09-30 千葉製粉株式会社 乾燥小胞体
DE4341472A1 (de) * 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
CA2202103C (fr) * 1996-04-11 2007-01-09 Toshiaki Tagawa Methode de preparation d'une vesicule fermee
RU2144352C1 (ru) * 1997-07-16 2000-01-20 Российский научно-исследовательский институт гематологии и трансфузиологии Способ получения лиофилизированных липосом
GB9813100D0 (en) * 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
IL144828A0 (en) * 1999-03-11 2002-06-30 Fujisawa Pharmaceutical Co A pipecolic acid derivative containing liposome composition
CA2309373A1 (fr) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Preparations topiques nouvelles
ES2251134T3 (es) * 1999-06-08 2006-04-16 Gentium S.P.A. Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos.
ATE273516T1 (de) * 1999-06-23 2004-08-15 Cornell Res Foundation Inc Entwässerung/rehydratisierung von markierten liposomen auf einer prüfeinrichtung
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
WO2002038128A1 (fr) * 2000-11-10 2002-05-16 Japan Science And Technology Corporation Procede de preparation d'une dispersion de microsome
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
US20050118250A1 (en) * 2001-11-13 2005-06-02 Paul Tardi Lipid carrier compositions with enhanced blood stability
ATE478337T1 (de) 2002-05-31 2010-09-15 Cornell Res Foundation Inc Methoden zum nachweis analyten in proben
DE10233632A1 (de) * 2002-07-24 2004-02-05 Wilex Ag Formulierungen von Phenylalanin-Derivaten
WO2004017944A1 (fr) * 2002-08-23 2004-03-04 Neopharm, Inc. Compositions de gemcitabine pour une administration de medicaments amelioree
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
CA2508279A1 (fr) * 2002-12-23 2004-07-22 Vical Incorporated Procede de lyophilisation de complexes d'acide nucleique/copolymere sequence/tensioactif cationique
US7381422B2 (en) * 2002-12-23 2008-06-03 Vical Incorporated Method for producing sterile polynucleotide based medicaments
US20060223050A1 (en) * 2003-08-06 2006-10-05 The Regents Of The University Of California Office Of Technology Transfer Therapeutic platelets and methods
AU2005251691A1 (en) * 2004-05-17 2005-12-22 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
FR2870741B1 (fr) * 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
CA2584583A1 (fr) * 2004-10-28 2006-05-11 Alza Corporation Formulations de liposomes lyophilises et methode associee
WO2006068759A2 (fr) * 2004-11-22 2006-06-29 Magellan Companies, Inc. Liposomes contenant des agents phytochimique et methodes de fabrication et d'utilisation desdits agents
EP1932517A3 (fr) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes contenant des dérivés de polyphénols et son procédé de post-chargement
US20090047336A1 (en) * 2007-08-17 2009-02-19 Hong Kong Baptist University novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
US8962015B2 (en) * 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
EP2317981B1 (fr) * 2008-07-24 2013-11-13 Amorepacific Corporation Granulé lamellaire multicouches et composition pour application externe sur la peau le contenant
CA2754896C (fr) * 2009-03-09 2017-11-28 Molecular Express, Inc. Procedes et compositions pour formulation liposomale d'antigenes et leurs utilisations
US9775819B2 (en) 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
WO2011100692A1 (fr) 2010-02-15 2011-08-18 The General Hospital Corporation Procédés et dispositifs pour la dissociation sélective de graisse viscérale par refroidissement commandé
EP2386647A1 (fr) * 2010-05-10 2011-11-16 Qiagen GmbH Procédé de transfection d'une cellule eucaryote
EP2471511A1 (fr) 2011-01-04 2012-07-04 Archivel Farma, SL Formulation de liposome adaptée pour le traitement ou la prévention de la tuberculose
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
US10076496B2 (en) * 2011-11-11 2018-09-18 The Chinese University Of Hong Kong Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
EA022183B1 (ru) * 2012-12-24 2015-11-30 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы цитохрома с
WO2016033384A1 (fr) 2014-08-28 2016-03-03 The General Hospital Corporation Suspensions injectables et procédés de fabrication et d'utilisation associés
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
DK3419572T3 (da) 2016-02-26 2026-06-29 Massachusetts Gen Hospital Systemer og fremgangsmåder til fremstilling og administrering af medicinsk isopslæmning
US20220273569A1 (en) * 2019-07-24 2022-09-01 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
CN114886785B (zh) * 2022-06-07 2023-02-03 美尚(广州)化妆品股份有限公司 一种三元冻干组合物及其在冻干制剂中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CH621479A5 (fr) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4460577A (en) * 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
CA1173360A (fr) * 1979-06-22 1984-08-28 Jurg Schrank Produits pharmaceutiques
JPS574913A (en) * 1980-06-11 1982-01-11 Green Cross Corp:The Urokinase preparation for oral administration
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US5008109A (en) * 1984-05-25 1991-04-16 Vestar, Inc. Vesicle stabilization
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
EP0208764A4 (fr) * 1985-01-11 1987-10-08 Univ California Procede de conservation de liposomes.
CA1256372A (fr) * 1985-04-11 1989-06-27 Koichiro Miyazima Procede de production de composes de liposomes
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
KR900700079A (ko) * 1988-01-12 1990-08-11 후지하라 도미오 누출방지 리포좀 제제
JPH02273538A (ja) * 1989-04-13 1990-11-08 Fuji Photo Film Co Ltd リポソームの保存方法
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials

Also Published As

Publication number Publication date
DK59691D0 (da) 1991-04-04
JP2792702B2 (ja) 1998-09-03
NO180363C (no) 1997-04-09
US5817334A (en) 1998-10-06
EP0437479A1 (fr) 1991-07-24
EP0437479B1 (fr) 1994-06-22
ATE107502T1 (de) 1994-07-15
IE64559B1 (en) 1995-08-23
NO901852D0 (no) 1990-04-26
AU612285B2 (en) 1991-07-04
IL91901A0 (en) 1990-06-10
DE68916439D1 (de) 1994-07-28
CA2000219A1 (fr) 1990-04-05
EP0437479A4 (en) 1991-10-16
AU4340089A (en) 1990-05-01
NO901852L (no) 1990-08-01
FI902249A0 (fi) 1990-05-04
WO1990003795A1 (fr) 1990-04-19
FI902249A7 (fi) 1990-05-04
IE893196L (en) 1990-04-05
NO180363B (no) 1996-12-30
DE68916439T2 (de) 1994-10-20
JPH04500803A (ja) 1992-02-13
IL91901A (en) 1993-06-10

Similar Documents

Publication Publication Date Title
DK59691D0 (da) Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring
ATE114156T1 (de) Herstellung von proteinen in aktiver form.
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
SE8903777L (sv) Liposome/doxorubicin, komposition och foerfarande
CA2113995A1 (fr) Utilisation d'acide gentisique ou d'alcool gentisique pour la stabilisation de peptides et de proteines radiomarques
EP0158277A3 (fr) Préparations implantables à libération contrôlée de peptides régulateurs et procédé pour leur fabrication
TR199802789T2 (xx) Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
IE881755L (en) Novel proteins with factor viii activity, process for their¹preparation using genetically engineered cells and¹pharmaceutical compositions containing them
DK164479C (da) Sucralfatsuspension og fremgangsmaade til fremstilling af denne
IT8620799A0 (it) Composizioni farmacueutiche adattivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, eprocedimento per prepararle.
FI102036B1 (fi) Menetelmä rasvaliukoisten aineiden stabiilien valmisteiden valmistamiseksi
EP0141374A3 (fr) Production de capsules utilisant des substrats biologiquement actifs
ES8305501A1 (es) Procedimiento para preparar un material de referencia o control de hemoglobina.
NO922953D0 (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
ES8607984A1 (es) Un procedimiento para cargar un polimero insoluble en agua yesponjable en agua con acetato de metilhidroxiprogesterona
ES8404160A1 (es) Un procedimiento para producir productos de plantas aromaticas.
EP0161007A3 (fr) Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
HUT35155A (en) Pesticide composition containing heterocyclic nitro-methylene derivatives as active substances and process for preparing the active substance
IL71702A0 (en) Biologically active polypeptides,their preparation,antibodies thereto and compositions containing them
EP0261648A3 (en) Cell membrane proteins, compositions containing them and procedure for their preparation
NO881942L (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
HUT33951A (en) Pesticide composition and process for producing tetrahydo-thio-pirane-3,5-dione-4-carboxamide derivatives utilizable as active agents
FI895899A7 (fi) Uudet trombolyyttiset proteiinit, menetelmä niiden valmistamiseksi ja näitä aktiiviaineina sisältävät lääkkeet
Salamah et al. Effect of the virulence associated 47 megadalton plasmid of Yersinia pestis on permeability to gentian violet and sensitivity to novobiocin